2hon MSN
A blood-based approach could enable personalized immunotherapy without the need for a tumor biopsy
In a study published in Cancer Discovery, cancer neoantigens and neoantigen-specific T cells were identified from patient ...
Technion-led study finds early changes in tumors’ immune environment may predict treatment success better than their initial ...
Cancer neoantigens and neoantigen-specific T cells were identified from patient blood samples by analyzing circulating tumor DNA (ctDNA) and immune cells, respectively, and they largely matched those ...
Between Immunotherapy and Daily Life When we hear the term "immunotherapy," it is easy to conjure up heavy images of cancer treatment or specialized hospitals. At the same time, our daily lives are ...
Many liver and lung cancers arise in tissue that's already been scarred by chronic disease, such as hepatitis, cirrhosis or ...
Two patients receive the same immunotherapy for the same cancer. In one, the tumor retreats and stays gone for years. In the ...
Prologue: The story of how I hated the season I loved mostI truly love the season of spring.The way the tense cold of winter ...
Immune signals linked to cancer-attacking cells were activated in lung cancer patients receiving immunotherapy when a traditional herbal formula was administere ...
Lawmakers say the proposed Medicare policy could make it harder for patients to access newer cancer treatments by ...
After the mice received the combination of five cytokine mRNAs and three tumor antigen mRNAs, the researchers observed less fibrotic material around the tumors and increased tumor cell necrosis. These ...
SAN FRANCISCO and SUZHOU, China, Sept. 28, 2026 /PRNewswire/ -- Innovent Biologics, Inc. (HKEX Stock Code: 01801), a ...
Fibrates in cholesterol drugs can stop liver cancers from recruiting 'traitor' immune cells, preventing immunotherapy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results